Cargando…

P-017: POINT-OF-CARE DIAGNOSTIC FOR QUANTIFICATION OF FOETAL HAEMOGLOBIN (HB F) LEVELS IN MONITORING HYDROXYUREA THERAPY FOR CHILDREN WITH SICKLE CELL DISEASE (SCD) IN GHANA

Detalles Bibliográficos
Autores principales: C., SEGBEFIA, Y., DEI-ADOMAKOH, E., MENSAH, P., THOTA, I., ODAME
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426818/
http://dx.doi.org/10.1097/01.HS9.0000872968.02648.ef
_version_ 1784778763598299136
author C., SEGBEFIA
Y., DEI-ADOMAKOH
E., MENSAH
P., THOTA
I., ODAME
author_facet C., SEGBEFIA
Y., DEI-ADOMAKOH
E., MENSAH
P., THOTA
I., ODAME
author_sort C., SEGBEFIA
collection PubMed
description
format Online
Article
Text
id pubmed-9426818
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94268182022-08-31 P-017: POINT-OF-CARE DIAGNOSTIC FOR QUANTIFICATION OF FOETAL HAEMOGLOBIN (HB F) LEVELS IN MONITORING HYDROXYUREA THERAPY FOR CHILDREN WITH SICKLE CELL DISEASE (SCD) IN GHANA C., SEGBEFIA Y., DEI-ADOMAKOH E., MENSAH P., THOTA I., ODAME Hemasphere Poster Presentations Lippincott Williams & Wilkins 2022-08-16 /pmc/articles/PMC9426818/ http://dx.doi.org/10.1097/01.HS9.0000872968.02648.ef Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Poster Presentations
C., SEGBEFIA
Y., DEI-ADOMAKOH
E., MENSAH
P., THOTA
I., ODAME
P-017: POINT-OF-CARE DIAGNOSTIC FOR QUANTIFICATION OF FOETAL HAEMOGLOBIN (HB F) LEVELS IN MONITORING HYDROXYUREA THERAPY FOR CHILDREN WITH SICKLE CELL DISEASE (SCD) IN GHANA
title P-017: POINT-OF-CARE DIAGNOSTIC FOR QUANTIFICATION OF FOETAL HAEMOGLOBIN (HB F) LEVELS IN MONITORING HYDROXYUREA THERAPY FOR CHILDREN WITH SICKLE CELL DISEASE (SCD) IN GHANA
title_full P-017: POINT-OF-CARE DIAGNOSTIC FOR QUANTIFICATION OF FOETAL HAEMOGLOBIN (HB F) LEVELS IN MONITORING HYDROXYUREA THERAPY FOR CHILDREN WITH SICKLE CELL DISEASE (SCD) IN GHANA
title_fullStr P-017: POINT-OF-CARE DIAGNOSTIC FOR QUANTIFICATION OF FOETAL HAEMOGLOBIN (HB F) LEVELS IN MONITORING HYDROXYUREA THERAPY FOR CHILDREN WITH SICKLE CELL DISEASE (SCD) IN GHANA
title_full_unstemmed P-017: POINT-OF-CARE DIAGNOSTIC FOR QUANTIFICATION OF FOETAL HAEMOGLOBIN (HB F) LEVELS IN MONITORING HYDROXYUREA THERAPY FOR CHILDREN WITH SICKLE CELL DISEASE (SCD) IN GHANA
title_short P-017: POINT-OF-CARE DIAGNOSTIC FOR QUANTIFICATION OF FOETAL HAEMOGLOBIN (HB F) LEVELS IN MONITORING HYDROXYUREA THERAPY FOR CHILDREN WITH SICKLE CELL DISEASE (SCD) IN GHANA
title_sort p-017: point-of-care diagnostic for quantification of foetal haemoglobin (hb f) levels in monitoring hydroxyurea therapy for children with sickle cell disease (scd) in ghana
topic Poster Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426818/
http://dx.doi.org/10.1097/01.HS9.0000872968.02648.ef
work_keys_str_mv AT csegbefia p017pointofcarediagnosticforquantificationoffoetalhaemoglobinhbflevelsinmonitoringhydroxyureatherapyforchildrenwithsicklecelldiseasescdinghana
AT ydeiadomakoh p017pointofcarediagnosticforquantificationoffoetalhaemoglobinhbflevelsinmonitoringhydroxyureatherapyforchildrenwithsicklecelldiseasescdinghana
AT emensah p017pointofcarediagnosticforquantificationoffoetalhaemoglobinhbflevelsinmonitoringhydroxyureatherapyforchildrenwithsicklecelldiseasescdinghana
AT pthota p017pointofcarediagnosticforquantificationoffoetalhaemoglobinhbflevelsinmonitoringhydroxyureatherapyforchildrenwithsicklecelldiseasescdinghana
AT iodame p017pointofcarediagnosticforquantificationoffoetalhaemoglobinhbflevelsinmonitoringhydroxyureatherapyforchildrenwithsicklecelldiseasescdinghana